MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q1
hinzugefügt 11.05.2023
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
32 M |
Marktkapitalisierung |
$ 36.5 M |
EBITDA (LTM) |
$ -60.3 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-1.8 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AbCellera Biologics
ABCL
|
$ 3.44 | -4.32 % | $ 1.03 B | Nasdaq Global Select Market |  Canada |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
ADMA Biologics
ADMA
|
$ 15.36 | -2.17 % | $ 3.66 B | Nasdaq Global Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 3.53 | -3.54 % | $ 116 M | Nasdaq Global Market | France |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Apellis Pharmaceuticals
APLS
|
$ 20.28 | 0.65 % | $ 2.56 B | Nasdaq Global Select Market,SPB | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | Canada |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Aptorum Group Limited
APM
|
$ 0.79 | -1.15 % | $ 4.31 M | Nasdaq Global Select Market | China |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.51 | 1.35 % | $ 385 M | Nasdaq Global Select Market | Britain |
 |
China SXT Pharmaceuticals
SXTC
|
$ 2.01 | -1.36 % | $ 2.86 M | Nasdaq Global Select Market | China |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 0.67 | 7.08 % | $ 624 K | Nasdaq Capital Market |  Israel |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Anika Therapeutics
ANIK
|
$ 14.05 | -1.44 % | $ 206 M | Nasdaq Global Select Market,SPB | USA |
 |
ANI Pharmaceuticals
ANIP
|
$ 74.36 | -1.64 % | $ 1.44 B | Nasdaq Global Market,SPB | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
Axsome Therapeutics
AXSM
|
$ 162.43 | 0.6 % | $ 8.08 B | Nasdaq Global Market,SPB | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 8.49 | -0.18 % | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
BridgeBio Pharma
BBIO
|
$ 65.66 | -0.78 % | $ 12.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
BioLineRx Ltd.
BLRX
|
$ 2.69 | -0.74 % | $ 908 M | Nasdaq Capital Market | Israel |
 |
BioMarin Pharmaceutical
BMRN
|
$ 61.3 | 1.21 % | $ 11.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 7.79 | -5.75 % | $ 1.28 B | NYSE | Britain |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |